Key result
Therapeutic lipid administration, including dietary and parenteral application, modulates leukocyte activity and influences the course of acute and chronic inflammatory diseases.
This review highlights the molecular mechanisms and clinical applications of therapeutic lipid administration in modulating leukocyte activity for chronic and acute inflammatory diseases.
Lipid therapies may aid inflammatory disease management; leaves open confirmation in prospective trials.
Selective dietary supplementation with lipids has long been used to influence the course of chronic inflammatory diseases. This review describes new aspects of the molecular mechanism of lipids to modulate leukocyte activity and highlights some recent clinical studies on therapeutic lipid administration. New promising advances in parenteral application of lipids as well as the impact on acute inflammatory disorders are discussed.
No takes yet. Share an insight, caveat, or question.
Mayer et al. (1998) conducted a review in Inflammatory diseases. Therapeutic lipid administration was evaluated. Therapeutic lipid administration, including dietary and parenteral application, modulates leukocyte activity and influences the course of acute and chronic inflammatory diseases.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: